男性女乳症手术市场－全球产业规模、份额、趋势、机会和预测：按年龄层、手术类型、最终用途、地区和竞争格局划分，2021-2031年

全球男性女乳症手术市场预计将从 2025 年的 1.8 亿美元成长到 2031 年的 2.9 亿美元，复合年增长率为 8.54%。

这些疗法旨在透过手术切除男性多余的乳房和脂肪组织，从而恢復更平坦、更具男性特征的胸部轮廓。推动这一市场发展的关键因素包括社会对男性美容治疗的接受度不断提高，以及男性对自身外观和心理健康的日益关注。此外，药物滥用和生活方式因素导致的荷尔蒙失衡现像日益普遍，也持续推动对矫正手术的稳定需求。

根据国际美容整形外科学会的数据，2023年全球共进行了352,302例男性女乳症手术。儘管数量庞大，但该市场在保险报销政策方面仍面临诸多障碍。大多数医疗机构将此类手术归类为美容手术而非医疗必需手术，导致患者自付费用高昂，限制了患者的就医途径，并阻碍了市场的整体成长。

市场驱动因素

社群媒体和名流文化对男性美学标准的日益影响，是全球男性女乳症手术市场的主要驱动力。男性经常接触到推崇完美「V」型胸部的数位内容，这促使他们自我评估胸部轮廓，并增加他们透过手术矫正过度发育组织的愿望。这种文化转变正在减少男性接受整形手术的偏见，并扩大了选择专业治疗的男性群体，他们不仅出于医疗原因，也出于美观方面的考虑。因此，国内的手术量依然保持强劲。根据美国美容整形外科学会2024年6月发布的报告，2023年美国共进行了21,043例男性女乳症手术，使其成为男性第二大最受欢迎的手术。

同时，可支配收入的成长以及人们在特定医疗项目上的消费意愿也支撑着市场价值。儘管大多数保险政策将男性乳房缩小手术归类为美容手术，并要求患者承担全部费用，但该领域仍在持续增长，克服了这些经济障碍。这一趋势体现在手术费用的飙升上，这不仅反映了通货膨胀的压力，也显示消费者对专业效果的重视。例如，美国整形外科医师协会在2024年6月报告称，该手术的平均费用已上涨至5,587美元。这种对美容计画的投入反映了整个产业的韧性，正如美国美容整形外科学会2024年的报告所示，手术总数较去年同期成长2.9%。

市场挑战

全球市场成长的一大障碍是，绝大多数保险公司将男性女乳症手术归类为美容手术。医疗保险支付方通常不承认该手术的医疗必要性，保险理赔经常被拒，迫使患者自行承担全部费用。这些费用不仅包括外科医生的费用，还包括手术室费用和麻醉费用，构成了一道高昂的经济门槛，实际上将许多患有此病却无力承担手术费用的患者拒之门外。

因此，这种限制性的保险报销环境严重阻碍了患者对整形手术的浓厚兴趣转化为实际手术。儘管病例数增加，社会接受度也有所提高，但由于经济限制导致患者难以获得手术机会，市场扩张速度仍然缓慢。美国整形外科医师协会的数据凸显了这个问题，报告显示，到2024年，男性女乳症缩小手术的数量预计仅增加2%。这一微弱的增长清楚地表明，保险支持的不足正在阻碍市场发展势头，并使该行业无法充分发挥其潜在需求。

市场趋势

随着越来越多的男性乳房增大手术从传统医院转移到专业的门诊中心，男性乳房增大市场格局正在重塑。这项转变主要源自于病人对隐私和效率的需求，对于寻求更私密治疗方式的男性而言，这两点尤其重要。专业机构提供了一种高效的治疗途径，避免了普通医院繁琐的行政流程和高昂的运营成本，同时确保了高标准的安全性，并方便患者就诊。美国美容外科协会（The Aesthetic Society）于2024年7月发布的数据也印证了这个趋势。该数据显示，2023年所有整形手术中有64%是在获得认证的手术中心进行的，这表明手术模式正在明显地从医院转向其他场所。

同时，随着能量辅助抽脂技术逐渐取代传统切除方法，临床通讯协定也不断发展。外科医生正在采用射频辅助和动力辅助溶脂等先进设备，这些设备具有高精度和减少疤痕的优点，可用于治疗腺体和脂肪组织。与传统手术刀技术不同，这些能量型系统能够同时消脂并收缩皮肤，从而达到「紧緻塑形」的效果。这满足了那些希望拥有优美胸型但又不想留下明显手术疤痕的患者的需求。这项技术的引入推动了手术数量的成长。 AirSculpt Technologies公司在2024年2月的报告中指出，使用其专有的能量型塑形技术的手术量年增了14.3%。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球男性女乳症手术市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依年龄组（18-40岁，40岁以上）
  • 依手术类型（抽脂、切除术）
  • 依最终用途（医院、整形外科中心）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美男性女乳症手术市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲男性女乳症手术市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区男性女乳症手术市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲男性女乳症手术市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲男性女乳症手术市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球男性女乳症手术市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Allergan Aesthetics
• Sientra
• Cynosure
• Cutera
• Galderma
• Heraeus
• Clarion Medical
• Mazor Robotics
• InMode

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Gynecomastia Procedures Market is projected to expand from a valuation of USD 0.18 Billion in 2025 to USD 0.29 Billion by 2031, reflecting a CAGR of 8.54%. These procedures entail the surgical reduction of excess glandular or fatty breast tissue in men, aiming to restore a flatter and more masculine chest profile. Key drivers propelling this market include broader societal acceptance of male aesthetic treatments and an intensified focus on physical appearance and mental well-being. Additionally, the rising prevalence of hormonal imbalances caused by medication use and lifestyle factors continues to fuel consistent demand for corrective interventions.

According to the International Society of Aesthetic Plastic Surgery, 352,302 gynecomastia procedures were performed globally in 2023. Despite this substantial volume, the market encounters a significant obstacle regarding insurance reimbursement policies. Most healthcare providers categorize this surgery as a cosmetic enhancement rather than a medical necessity, leading to steep out-of-pocket costs that restrict patient access and hinder overall market expansion.

Market Driver

The increasing influence of social media and celebrity culture on male beauty standards acts as a primary catalyst for the global gynecomastia procedures market. Men are frequently exposed to digital content that glorifies a sculpted, "V-taper" physique, which fosters critical self-assessment of chest contours and fuels the desire for surgical correction of overdeveloped tissue. This cultural shift has destigmatized male cosmetic interventions, prompting a broader demographic to pursue professional treatment for aesthetic improvements rather than solely medical reasons. Consequently, procedure volumes remain robust nationally, with The Aesthetic Society reporting in June 2024 that gynecomastia treatment became the second most popular surgical procedure for men in the U.S. during 2023, totaling 21,043 operations.

Simultaneously, rising disposable incomes and a willingness to spend on elective medical treatments are sustaining market value. Although most insurance policies classify male breast reduction as cosmetic, forcing patients to bear the full financial burden, the sector continues to thrive despite these economic barriers. This trend is reflected in escalating surgical costs, which signal both inflationary pressures and the premium consumers place on specialized results; for instance, the American Society of Plastic Surgeons noted in June 2024 that the average surgeon fee for this procedure rose to $5,587. This investment in aesthetic improvement mirrors broader industry resilience, as evidenced by The Aesthetic Society's 2024 report showing a 2.9 percent year-over-year increase in total surgical volume.

Market Challenge

A major barrier to the growth of the global market is the classification of gynecomastia surgery as a cosmetic enhancement by the majority of insurance providers. Since healthcare payers often deem this procedure not medically necessary, coverage applications are frequently denied, forcing patients to assume the full financial liability. This burden encompasses not only the surgeon's fee but also facility and anesthesia costs, creating a high economic threshold that effectively excludes a significant portion of the addressable population who suffer from the condition but cannot afford elective surgery.

Consequently, this restrictive reimbursement landscape severely limits the conversion of high patient interest into actual surgical volume. Despite the increasing incidence of the condition and greater social acceptance, the market struggles to expand rapidly as financial constraints hamper accessibility. Data from the American Society of Plastic Surgeons highlights this issue, reporting that gynecomastia reduction procedures increased by only 2% in 2024. This marginal growth rate clearly indicates that the lack of insurance support is stifling market momentum and preventing the industry from fully realizing the underlying demand.

Market Trends

The operational landscape of the gynecomastia market is being reshaped by a shift in surgical volumes from traditional hospitals to specialized ambulatory centers. This transition is largely driven by a demand for greater patient privacy and efficiency, which are crucial for the male demographic seeking discretion. Specialized facilities provide a streamlined care pathway that avoids the administrative burdens and high overhead costs of general hospitals, making the procedure more accessible while ensuring high safety standards. This preference is supported by data from The Aesthetic Society, which reported in July 2024 that 64% of all cosmetic surgical procedures in 2023 were performed in Accredited Surgical Centers, marking a distinct departure from hospital settings.

Concurrently, clinical protocols are evolving as energy-assisted liposuction technologies increasingly replace traditional excision methods. Surgeons are adopting advanced tools like radiofrequency-assisted or power-assisted lipolysis to treat glandular tissue and fat with superior precision and reduced scarring. Unlike standard scalpel-based techniques, these energy-based systems enable simultaneous fat removal and skin retraction, delivering a "shrink-wrapping" effect that appeals to patients wanting a sculpted chest without significant surgical marks. This technological adoption is driving volume growth, as demonstrated by AirSculpt Technologies' February 2024 report, which noted a 14.3% year-over-year increase in case volume attributed to their proprietary energy-based body contouring techniques.

Key Market Players

• Allergan Aesthetics
• Sientra
• Cynosure
• Cutera
• Galderma
• Heraeus
• Clarion Medical
• Mazor Robotics
• InMode

Report Scope

In this report, the Global Gynecomastia Procedures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gynecomastia Procedures Market, By Age Group

• 18-40
• Above 40

Gynecomastia Procedures Market, By Procedure Type

• Liposuction
• Excision

Gynecomastia Procedures Market, By End-Use

• Hospitals
• Cosmetic Surgery Center

Gynecomastia Procedures Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gynecomastia Procedures Market.

Available Customizations:

Global Gynecomastia Procedures Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gynecomastia Procedures Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Age Group (18-40, Above 40)
  • 5.2.2. By Procedure Type (Liposuction, Excision)
  • 5.2.3. By End-Use (Hospitals, Cosmetic Surgery Center)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Gynecomastia Procedures Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Age Group
  • 6.2.2. By Procedure Type
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Gynecomastia Procedures Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Age Group
      • 6.3.1.2.2. By Procedure Type
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Gynecomastia Procedures Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Age Group
      • 6.3.2.2.2. By Procedure Type
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Gynecomastia Procedures Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Age Group
      • 6.3.3.2.2. By Procedure Type
      • 6.3.3.2.3. By End-Use

7. Europe Gynecomastia Procedures Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Age Group
  • 7.2.2. By Procedure Type
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Gynecomastia Procedures Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Age Group
      • 7.3.1.2.2. By Procedure Type
      • 7.3.1.2.3. By End-Use
  • 7.3.2. France Gynecomastia Procedures Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Age Group
      • 7.3.2.2.2. By Procedure Type
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Gynecomastia Procedures Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Age Group
      • 7.3.3.2.2. By Procedure Type
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Gynecomastia Procedures Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Age Group
      • 7.3.4.2.2. By Procedure Type
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Gynecomastia Procedures Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Age Group
      • 7.3.5.2.2. By Procedure Type
      • 7.3.5.2.3. By End-Use

8. Asia Pacific Gynecomastia Procedures Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Age Group
  • 8.2.2. By Procedure Type
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Gynecomastia Procedures Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Age Group
      • 8.3.1.2.2. By Procedure Type
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Gynecomastia Procedures Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Age Group
      • 8.3.2.2.2. By Procedure Type
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Gynecomastia Procedures Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Age Group
      • 8.3.3.2.2. By Procedure Type
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Gynecomastia Procedures Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Age Group
      • 8.3.4.2.2. By Procedure Type
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Gynecomastia Procedures Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Age Group
      • 8.3.5.2.2. By Procedure Type
      • 8.3.5.2.3. By End-Use

9. Middle East & Africa Gynecomastia Procedures Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Age Group
  • 9.2.2. By Procedure Type
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Gynecomastia Procedures Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Age Group
      • 9.3.1.2.2. By Procedure Type
      • 9.3.1.2.3. By End-Use
  • 9.3.2. UAE Gynecomastia Procedures Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Age Group
      • 9.3.2.2.2. By Procedure Type
      • 9.3.2.2.3. By End-Use
  • 9.3.3. South Africa Gynecomastia Procedures Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Age Group
      • 9.3.3.2.2. By Procedure Type
      • 9.3.3.2.3. By End-Use

10. South America Gynecomastia Procedures Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Age Group
  • 10.2.2. By Procedure Type
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Gynecomastia Procedures Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Age Group
      • 10.3.1.2.2. By Procedure Type
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Colombia Gynecomastia Procedures Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Age Group
      • 10.3.2.2.2. By Procedure Type
      • 10.3.2.2.3. By End-Use
  • 10.3.3. Argentina Gynecomastia Procedures Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Age Group
      • 10.3.3.2.2. By Procedure Type
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Gynecomastia Procedures Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Allergan Aesthetics
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sientra
• 15.3. Cynosure
• 15.4. Cutera
• 15.5. Galderma
• 15.6. Heraeus
• 15.7. Clarion Medical
• 15.8. Mazor Robotics
• 15.9. InMode

16. Strategic Recommendations

17. About Us & Disclaimer